RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
about
Selective use of sorafenib in the treatment of thyroid cancerMolecular Targeted Therapies of Aggressive Thyroid CancerHypothesis: Artifacts, Including Spurious Chimeric RNAs with a Short Homologous Sequence, Caused by Consecutive Reverse Transcriptions and Endogenous Random PrimersNodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literatureEarly cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigationsMolecular pathogenesis and mechanisms of thyroid cancerCytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patientsCytological diagnosis of adult-type fibrosarcoma of the neck in an elderly patient. Report of one case and review of the literatureGenetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancerBRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature ReviewRET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.Thyroid cancer: molecular aspects and new therapeutic strategies.New insight into the treatment of advanced differentiated thyroid cancer.Recent progress of genome study for anaplastic thyroid cancer.Novel targets in non-small cell lung cancer: ROS1 and RET fusionsMolecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.Genetics and epigenetics of sporadic thyroid cancer.Proteome analysis in thyroid pathology.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection.Ras oncoprotein disrupts the TSH/CREB signaling upstream adenylyl cyclase in human thyroid cell.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.Values of molecular markers in the differential diagnosis of thyroid abnormalities.The role of molecular diagnostic testing in the management of thyroid nodules.Rethinking the role of oncogenes in papillary thyroid cancer initiation.Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.Sorafenib in the treatment of thyroid cancer.Molecular testing in the diagnosis of differentiated thyroid carcinomas
P2860
Q26752891-2BB8DF4F-6A15-4ABF-93E3-781ACFB80CF8Q26774734-70FD65C5-ACA5-4330-9C19-BA5F610FC72AQ26820767-4E034E93-679E-444D-8B4E-BA1E70F85F2EQ27025120-B4BE8824-0E6F-4533-BDD6-5C10A19FD838Q27690371-982CEE84-DAF1-41E3-8706-DC877581510AQ31159590-190360B8-80AC-4D58-BF3F-8C37E11E434EQ34329018-8CA9B381-53F5-465A-886C-2C11450818A3Q35050925-3A6C77AC-C8A5-4D99-AAD5-08FC9A157B09Q35050977-023796C8-5D4A-4020-90E1-4BBB64A2E73EQ35051065-17B64B1D-A699-430D-A2C5-03B91306B21DQ35051461-2D1E29DC-5BC2-4391-B4EB-4DCDFA93A451Q35064835-343086A1-01A3-4DC6-ADC5-24D67459C637Q35609167-CB183D1A-1605-42C5-998E-0A499B15F48EQ35971877-71962BDE-C52A-4A23-98AF-A53557BD5DF9Q36111541-36520F4B-B380-44C1-A015-328F393A58F1Q36528466-8DC57C80-6547-4EF2-A8D7-4CBC20089296Q36992782-103C0889-0C8E-4BC5-B73F-6EBF0509B11DQ37038500-4FAC9FCE-03CD-483B-84EB-678B97346255Q38124903-2CD03C2A-7137-4873-A877-B12FF59BC8D1Q38128097-C35E9A48-C3A5-4A1A-AF41-C43EA865CEEEQ38541463-45CFA55B-6F4C-4FA8-8976-C7F0B33C6130Q38657760-4603F007-F07E-4E04-A040-1EE18E550973Q38659248-08BE273B-20AE-4002-9F45-CFB626DFB424Q38995868-4B3EF3DB-85C0-4270-8C83-CA2DD9427851Q39002421-EEA80DC0-AED5-48CB-90C7-953CBB891591Q39051174-0D69FD3C-AE0C-44F3-806D-BD10EC41F265Q39250953-B00553D5-84DB-4B61-B646-97B0A266EFD4Q41878891-DF4476AA-D8AA-4B5E-8944-2CF9B4D390C4Q42174969-0686331B-BF54-476D-BD29-03B8B603ADDFQ43005022-D46FF45F-041A-4B45-A80F-EE39B1FDBD3BQ43429193-98B3A8EB-4546-419A-8C19-3BB012A4B1FEQ46475619-7EB5DD9B-80BA-4648-8E07-E2E75EF55067Q46527691-491F1DB2-14D3-42D4-ACA2-05EF6E0EC684Q52778675-59904916-124D-40E9-A9DC-4D8E80479774Q55053748-A18C92F2-DC1D-4EB9-849E-15006309C232Q58805430-3DD9793E-9782-42AB-94F6-24677719A781
P2860
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@en
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@nl
type
label
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@en
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@nl
prefLabel
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@en
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
@nl
P2093
P356
P1476
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint
@en
P2093
Anna Guerra
Maria Rosaria Sapio
Mario Vitale
P304
P356
10.1530/EJE-11-0499
P577
2011-07-12T00:00:00Z